Benjamin G. Neel, MD, PhD
Professor of Medicine, NYU School of Medicine
Director, Laura and Isaac Perlmutter Cancer Center
contact : firstname.lastname@example.org
Toshiyuki Araki, PhD
Research Assistant Professor
Ph.D., 2000, Protein Research Institute, Suita Japan
My work focuses on the Role of RAS/ERK signaling in human development and cancers.
contact : email@example.com
Yi Ban, PhD
Ph.D., 2013, Molecular and Cellular Pharmacology. Rutgers University
Postdoc: Weill Cornell Medicine, Immunotherapy of Lung Cancer.
I study the role of SHP2 in immune responses against Kras-mutant lung cancer.
Post Doctoral Fellows
Yashika Agrawal, PhD
Ph.D., 2022, National Centre for Cell Science, Pune, India
Studying the mechanism of action of SHP2.
Abhishek Bhardwaj, PhD
Ph.D., 2016, National Institute of Immunology, JNU, New Delhi/ India
Investigating the role of PTP1B in regulating RNF213, the identification and function of RNF213 substrates and the detailed mechanism of RNF213 ubiquitin ligase activity.
contact : firstname.lastname@example.org
Mitchell Geer, PhD
Ph.D., 2017, University of Birmingham, UK
I am studying kinase-phosphatase mediated signaling in leukemia development, particularly the role of specific ERK isoforms in normal hematopoiesis and myeloproliferative disorders.
contact : email@example.com
Jianmei Hou, PhD
Ph.D., 2022, Monash University, AU
I am studying an air–liquid interface organoid model for high grade serous tubo-ovarian carcinoma and the tumor microenvironment.
contact : firstname.lastname@example.org
Richard Kurupi, PhD
Ph.D., 2022, Virginia Commonwealth University, USA
I am studying the role of SHP2 in RAS/ERK pathway activation
Suman Mukhopadhyay, PhD
Ph.D., 2015, CUNY Graduate Center, City University of New York, USA
Post-Doctoral Fellow, NCI RAS Initiative, Frederick National Laboratory for Cancer Research
I am studying the mechanisms of response and resistance to KRAS, SHP2 inhibitors in lung cancer.
Oscar Pundel, PhD
PhD, Biophysics, Queen Mary University of London
M.Sc Biochemistry Ecole Polytechnique Fédérale de Lausanne
B.Sc Chemistry Ecole Polytechnique Fédérale de Lausanne
My work focuses around the generation of novel high grade serous ovarian cancer organoid models and their study in genetic instability, 3D chromatin architecture and immune regulation in syngeneic mice models.
BA in Biological Sciences from Cornell University, 2015
I study the role of PZR in the immune system as well as the role of shp2 binding proteins in downregulating the immune response in cancer.
Visiting Graduate Student
I am studying Novel LZTR1 interacting proteins.
MS of Biology from NYU, 2014
I am studying mechanisms of cancer cell resistance to SHP2 inhibitors.
contact : email@example.com
Kiyomi Araki, PhD
contact : firstname.lastname@example.org